This article was originally published in The Tan Sheet
Indiana lowers annual PSE limit; Children’s Tylenol recalled in South Korea; Hain Celestial acquires Ella's Kitchen; spiked supplement recalls; FDA says EuroPharma products are misbranded; Xymogen blames third party for supplement recalls; Pure Herbs recalls Protein Extract.
You may also be interested in...
Tennessee’s meth lab seizures are up this year, but CHPA says that’s because more labs are uncovered through the state’s participation in the NPLEx stop-sale system. Rx-only bills have stalled in several states, including Indiana, where lawmakers passed a bill to cap PSE purchases at about 61 grams per year.
A report from the US FDA says the agency will focus on updating its premarket submission portal, training staff and taking additional steps to start taking in applications for ASCA pilot participant sponsors.
With a late-stage compound on its hands, MGB is currently in discussions with several biotech and pharma companies and also with venture capitalists to continue late-stage development of a novel antibiotic which could transform treatment of Clostridium difficile.